| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ACE inhibitors, heart failure and evidence-based medicine
|
|
|
2000
|
|
9 |
p. 9-11
|
artikel
|
| 2 |
Addendum: the use of medicines in exceptional circumstances in Spain: adding perspective to early access
|
Frutos Pérez-Surio, Alberto
|
|
2019
|
|
9 |
p. 429-430
|
artikel
|
| 3 |
Adis Summary of Research: Safety, Effectiveness, and Immunogenicity 6 Months After BNT162B2 mRNA Vaccine in Frail Nursing Home Residents
|
Paik, Julia
|
|
|
|
9 |
p. 317-318
|
artikel
|
| 4 |
Aminoglycoside use in critically ill patients requires careful regimen planning and drug monitoring to avoid nephrotoxicity
|
|
|
2013
|
|
9 |
p. 282-286
|
artikel
|
| 5 |
Amphetamine extended-release oral suspension (Adzenys ER™) and orally disintegrating tablets (Adzenys XR-ODT®) in attention-deficit hyperactivity disorder: a profile of their use
|
Lyseng-Williamson, Katherine A.
|
|
2018
|
|
9 |
p. 411-419
|
artikel
|
| 6 |
A new approach to pharmaceutical care: experiences with the ‘Eichberger’ model in a psychiatric clinic in Germany
|
Hahn, Martina
|
|
2012
|
|
9 |
p. 24-26
|
artikel
|
| 7 |
As nosocomial bacterial infections evolve, so do treatment and prevention strategies
|
|
|
2000
|
|
9 |
p. 3-8
|
artikel
|
| 8 |
Associations between Drug Burden Index, medication appropriateness and patient-reported outcomes in the community pharmacy setting in Malaysia
|
Hasan, Syed Shahzad
|
|
2018
|
|
9 |
p. 437-443
|
artikel
|
| 9 |
Bolus administration further enhances role of thrombolytics in initial management of myocardial infarction
|
|
|
2001
|
|
9 |
p. 9-12
|
artikel
|
| 10 |
Causes, Nature and Toxicology of Tramadol-Associated Deaths Reported in the Peer-Reviewed Literature: A Systematic Review of Case Studies and Case Series
|
Alrashdi, Saud
|
|
|
|
9 |
p. 422-432
|
artikel
|
| 11 |
Clinicians must remain alert for interactions between herbal medicines and prescribed drugs
|
|
|
2002
|
|
9 |
p. 17-21
|
artikel
|
| 12 |
Cobicistat: a guide to its use as a pharmacokinetic enhancer of atazanavir and darunavir in HIV-1 infection
|
Lyseng-Williamson, Katherine A.
|
|
2014
|
|
9 |
p. 309-315
|
artikel
|
| 13 |
Combined hyperlipidaemia requires aggressive management to reduce cardiovascular risk
|
|
|
2002
|
|
9 |
p. 7-10
|
artikel
|
| 14 |
Community pharmacists’ attitudes towards adverse drug reaction reporting and their knowledge of the new pharmacovigilance legislation in the southern region of Portugal: a mixed methods study
|
Duarte, Maria
|
|
2015
|
|
9 |
p. 316-322
|
artikel
|
| 15 |
Compliance a key consideration in treating concurrent gonorrhoea and Chlamydia infection
|
|
|
2001
|
|
9 |
p. 6-9
|
artikel
|
| 16 |
Consider clinically relevant pharmacokinetic drug interactions when co-prescribing drugs in attention-deficit/hyperactivity disorder
|
Kim, Esther
|
|
|
|
9 |
p. 386-388
|
artikel
|
| 17 |
Consider comorbidities, concomitant medications and organ function when treating chronic urticaria in older adults
|
Nie, Tina
|
|
|
|
9 |
p. 319-323
|
artikel
|
| 18 |
Consider dosing, monitoring and complications when using anticoagulants to treat acute venous thromboembolism in paediatric patients
|
|
|
2015
|
|
9 |
p. 307-310
|
artikel
|
| 19 |
Consider fibromyalgia in older patients with chronic widespread pain
|
Fenton, Caroline
|
|
|
|
9 |
p. 394-399
|
artikel
|
| 20 |
Consider non-stimulants or adjunctive therapy when response to stimulants is inadequate in patients with attention-deficit/hyperactivity disorder
|
|
|
2014
|
|
9 |
p. 325-329
|
artikel
|
| 21 |
Consider pharmacotherapy for antipsychotic-induced orthostatic hypotension only if nonpharmacological measures fail
|
|
|
2012
|
|
9 |
p. 19-23
|
artikel
|
| 22 |
Consider potential alterations in drug metabolism and excretion when selecting antiepileptics in patients with renal or hepatic impairment
|
|
|
2014
|
|
9 |
p. 330-334
|
artikel
|
| 23 |
Correction to: Aprotinin in adults at high risk of major blood loss during isolated CABG with cardiopulmonary bypass: a profile of its use in the EU
|
Lyseng‑Williamson, Katherine A.
|
|
|
|
9 |
p. 426
|
artikel
|
| 24 |
Correction to: Caplacizumab in acquired thrombotic thrombocytopenic purpura: a profile of its use
|
Blair, Hannah A.
|
|
2019
|
|
9 |
p. 459
|
artikel
|
| 25 |
Correction to: Ivosidenib in relapsed or refractory acute myeloid leukemia: a profile of its use in the USA
|
McCafferty, Emma H.
|
|
2019
|
|
9 |
p. 460
|
artikel
|
| 26 |
Correction to: K-haler® breath-triggered inhaler: a profile of the properties of the device
|
Deeks, Emma D.
|
|
2019
|
|
9 |
p. 461
|
artikel
|
| 27 |
Cost-effectiveness analysis of budesonide/formoterol (Symbicort®) as needed for mild asthma in Malaysia
|
Raja Gopal, Vieshal
|
|
|
|
9 |
p. 439-451
|
artikel
|
| 28 |
CT-P13 (an infliximab biosimilar): a guide to its use in the EU
|
McKeage, Kate
|
|
2015
|
|
9 |
p. 296-301
|
artikel
|
| 29 |
Daclizumab has a definite role in preventing acute rejection in renal transplants and may be beneficial in other solid organ transplants
|
|
|
2002
|
|
9 |
p. 1-4
|
artikel
|
| 30 |
Design and implementation of an online tool for managing the availability of high-cost perishable medicines
|
Galisteo, Myriam Gallego
|
|
|
|
9 |
p. 406-415
|
artikel
|
| 31 |
Diagnose and treat paediatric-onset multiple sclerosis promptly to delay physical worsening and cognitive decline
|
Hoy, Sheridan M.
|
|
|
|
9 |
p. 389-393
|
artikel
|
| 32 |
Dimethyl fumarate: a guide to its use in relapsing-remitting multiple sclerosis
|
Keating, Gillian M.
|
|
2014
|
|
9 |
p. 303-308
|
artikel
|
| 33 |
Drug administration errors in infants: don’t blame individuals, fix the system
|
|
|
2000
|
|
9 |
p. 11-13
|
artikel
|
| 34 |
Efficacy and safety of intra-articular injection with triamcinolone acetonide for patients with rheumatoid arthritis
|
Yoshii, Ichiro
|
|
|
|
9 |
p. 404-412
|
artikel
|
| 35 |
Epirubicin: better option for patients at low risk of tumour recurrence after TUR
|
|
|
2000
|
|
9 |
p. 1-5
|
artikel
|
| 36 |
Erratum to: Buprenorphine oral lyophilisate (Espranor®) in the substitution treatment of opioid dependence: a profile of its use
|
Lyseng-Williamson, Katherine A.
|
|
2017
|
|
9 |
p. 448
|
artikel
|
| 37 |
Erratum to Case definitions for public health surveillance
|
Wharton, M.
|
|
2000
|
|
9 |
p. 8
|
artikel
|
| 38 |
Erratum to: Vedolizumab in moderately to severely active ulcerative colitis or Crohn’s disease: a guide to its use
|
Lyseng-Williamson, Katherine A.
|
|
2016
|
|
9 |
p. 406
|
artikel
|
| 39 |
Evaluation of management and factors associated with hypertension control in hemodialysis patients at a tertiary-care hospital in Pakistan
|
Gulalai,
|
|
|
|
9 |
p. 396-403
|
artikel
|
| 40 |
Examine the skin and thoroughly review medical/medication history when considering a diagnosis of drug-induced pigmentation
|
|
|
2019
|
|
9 |
p. 418-423
|
artikel
|
| 41 |
Fibromyalgia: an enigmatic condition with no defined treatment
|
|
|
2002
|
|
9 |
p. 11-13
|
artikel
|
| 42 |
First reports of adverse drug reactions
|
|
|
2016
|
|
9 |
p. 390-391
|
artikel
|
| 43 |
First reports of adverse drug reactions
|
|
|
2017
|
|
9 |
p. 429
|
artikel
|
| 44 |
First reports of adverse drug reactions
|
|
|
|
|
9 |
p. 330
|
artikel
|
| 45 |
First reports of adverse drug reactions (ADRs) in recent weeks
|
|
|
2002
|
|
9 |
p. 21-22
|
artikel
|
| 46 |
First reports of adverse drug reactions (ADRs) in recent weeks
|
|
|
2001
|
|
9 |
p. 15
|
artikel
|
| 47 |
First reports of adverse drug reactions (ADRs) in recent weeks
|
|
|
|
|
9 |
p. 17-18
|
artikel
|
| 48 |
First reports of adverse drug reactions and interactions
|
|
|
|
|
9 |
p. 382-385
|
artikel
|
| 49 |
First reports of adverse drug reactions in recent weeks
|
|
|
2015
|
|
9 |
p. 311-312
|
artikel
|
| 50 |
First reports of serious adverse drug reactions in recent weeks
|
|
|
2014
|
|
9 |
p. 335-336
|
artikel
|
| 51 |
First reports of serious adverse drug reactions in recent weeks
|
|
|
2013
|
|
9 |
p. 280-281
|
artikel
|
| 52 |
First reports of serious adverse drug reactions in recent weeks
|
|
|
2012
|
|
9 |
p. 17-18
|
artikel
|
| 53 |
Following the six principles developed by the STAY initiative may improve treatment adherence in patients with schizophrenia
|
|
|
2013
|
|
9 |
p. 287-290
|
artikel
|
| 54 |
Gastrointestinal complications in patients on mechanical ventilation can be prevented and treated with various drugs
|
|
|
|
|
9 |
p. 6-10
|
artikel
|
| 55 |
Gout plus cardiovascular disease is painful, but treatable
|
Fenton, Caroline
|
|
|
|
9 |
p. 407-414
|
artikel
|
| 56 |
Hialid®/Hyalein® (sodium hyaluronate) ophthalmic solution in dry eye syndrome: a profile of its use
|
McKeage, Kate
|
|
2018
|
|
9 |
p. 405-410
|
artikel
|
| 57 |
High-dose hydroxocobalamin in end-stage liver disease and liver transplantation
|
Sakpal, Sujit Vijay
|
|
2019
|
|
9 |
p. 442-446
|
artikel
|
| 58 |
High-dose hydroxocobalamin in end-stage liver disease and liver transplantation
|
Sakpal, Sujit Vijay
|
|
|
|
9 |
p. 442-446
|
artikel
|
| 59 |
Hospitalized elderly: investigating newly prescribed atypical antipsychotics during the hospital stay and their continuation on discharge
|
Elbeddini, Ali
|
|
|
|
9 |
p. 421-425
|
artikel
|
| 60 |
Ivermectin in rosacea: a guide to its use in the EU
|
Kim, Esther S.
|
|
2016
|
|
9 |
p. 357-362
|
artikel
|
| 61 |
Knowledge and beliefs towards universal safety precautions during the coronavirus disease (COVID-19) pandemic among the Indian public: a web-based cross-sectional survey
|
Gudi, Sai Krishna
|
|
|
|
9 |
p. 413-420
|
artikel
|
| 62 |
Ledipasvir/sofosbuvir in chronic hepatitis C: a guide to its use in the EU
|
Keating, Gillian M.
|
|
|
|
9 |
p. 289-295
|
artikel
|
| 63 |
Ledipasvir/sofosbuvir in chronic hepatitis C: a guide to its use in the EU
|
Keating, Gillian M.
|
|
2015
|
|
9 |
p. 289-295
|
artikel
|
| 64 |
Linzagolix in moderate to severe symptoms of uterine fibroids: a profile of its use
|
Fung, Simon
|
|
|
|
9 |
p. 309-316
|
artikel
|
| 65 |
Linzolid: first of a new drug class for Gram-positive infections
|
|
|
2001
|
|
9 |
p. 1-6
|
artikel
|
| 66 |
Lipid-lowering agents for the treatment of hyperlipidemia in patients with chronic kidney disease and end-stage renal disease on dialysis: a review
|
Pryor, Joseph B.
|
|
2019
|
|
9 |
p. 431-441
|
artikel
|
| 67 |
Lixisenatide: a guide to its use as add-on therapy in type 2 diabetes mellitus
|
Lyseng-Williamson, Katherine A.
|
|
2013
|
|
9 |
p. 253-259
|
artikel
|
| 68 |
Manage chronic pruritus in the elderly with various agents depending on the pathophysiology and aetiology of the condition
|
|
|
2015
|
|
9 |
p. 302-306
|
artikel
|
| 69 |
Management and outcome of Stevens–Johnson syndrome and toxic epidermal necrolysis in patients admitted to Kenyatta National Hospital
|
Irungu, K. K.
|
|
2018
|
|
9 |
p. 444-450
|
artikel
|
| 70 |
Manage neonatal sepsis with prompt initiation of empirical antibacterial therapy, followed by targeted therapy
|
|
|
2014
|
|
9 |
p. 316-320
|
artikel
|
| 71 |
Manage pain before, during and after total knee arthroplasty using a multimodal approach to analgesia
|
|
|
2014
|
|
9 |
p. 321-324
|
artikel
|
| 72 |
Manage severe Cushing’s syndrome with urgent control of metabolic disturbances and serum cortisol levels
|
|
|
2016
|
|
9 |
p. 385-389
|
artikel
|
| 73 |
Manage truncal acne and scarring the same as for facial acne, but more trunk-specific therapies are warranted
|
Kang, Connie
|
|
|
|
9 |
p. 324-329
|
artikel
|
| 74 |
Managing glucose-related adverse events of antipsychotics is worth the effort
|
Fenton, Caroline
|
|
|
|
9 |
p. 415-421
|
artikel
|
| 75 |
May direct-acting antiviral regimens for chronic hepatitis C virus infections have neuropsychiatric adverse drug reactions? A pilot study conducted in patients receiving sofosbuvir-based regimens in the real-life setting
|
Simeone, Davide
|
|
2017
|
|
9 |
p. 442-447
|
artikel
|
| 76 |
Methoxyflurane inhalation vapour in trauma pain: a profile of its use in the EU
|
Blair, Hannah A.
|
|
2017
|
|
9 |
p. 403-408
|
artikel
|
| 77 |
Metyrapone in Cushing’s syndrome: a profile of its use
|
Al-Salama, Zaina T.
|
|
|
|
9 |
p. 393-406
|
artikel
|
| 78 |
Multiple myeloma: QALY gains from optimal therapy
|
|
|
2000
|
|
9 |
p. 12-16
|
artikel
|
| 79 |
Nanofiltered human C1 inhibitor concentrate (Cinryze®): a guide to its use in hereditary angioedema in the EU
|
Lyseng-Williamson, Katherine A.
|
|
2013
|
|
9 |
p. 260-267
|
artikel
|
| 80 |
New in the marketplace
|
|
|
2002
|
|
9 |
p. 26
|
artikel
|
| 81 |
New in the marketplace
|
|
|
2001
|
|
9 |
p. 16
|
artikel
|
| 82 |
No simple answer to the question of how drug therapies impact AD costs
|
|
|
2000
|
|
9 |
p. 13-15
|
artikel
|
| 83 |
Olanzapine and clozapine use in a woman with schizophrenia during consecutive pregnancies: a case report
|
Köse Çınar, Rugül
|
|
2016
|
|
9 |
p. 403-405
|
artikel
|
| 84 |
Olmesartan medoxomil: a guide to its use as monotherapy or in fixed-dose combinations with amlodipine and/or hydrochlorothiazide
|
Lyseng-Williamson, Katherine A.
|
|
2016
|
|
9 |
p. 369-380
|
artikel
|
| 85 |
Olmesartan Medoxomil: profile report
|
|
|
2002
|
|
9 |
p. 5-7
|
artikel
|
| 86 |
Outcome measures in pediatric polypharmacy research: a scoping review
|
Golchin, Negar
|
|
2019
|
|
9 |
p. 447-458
|
artikel
|
| 87 |
Oxycodone prolonged release: a guide to its use in the EU
|
Deeks, Emma D.
|
|
2016
|
|
9 |
p. 363-368
|
artikel
|
| 88 |
Paradigm shift of drug information centers during the COVID-19 pandemic
|
Khatiwada, Asmita Priyadarshini
|
|
|
|
9 |
p. 389-395
|
artikel
|
| 89 |
Personalize protocols when deprescribing psychotropics used to manage behavioural changes in individuals with dementia
|
|
|
2019
|
|
9 |
p. 424-428
|
artikel
|
| 90 |
Phenobarbital monotherapy for alcohol withdrawal syndrome in the non-intensive care unit setting: a review
|
Phan, Stephanie V.
|
|
2018
|
|
9 |
p. 429-436
|
artikel
|
| 91 |
Pitavastatin: a guide to its use in hypercholesterolaemia and mixed dyslipidaemia
|
Lyseng-Williamson, Katherine A.
|
|
2012
|
|
9 |
p. 5-9
|
artikel
|
| 92 |
Preventing and managing dimethyl fumarate-related adverse effects in patients with multiple sclerosis may improve adherence
|
Writers, Adis Medical
|
|
2018
|
|
9 |
p. 420-424
|
artikel
|
| 93 |
Prevent postoperative recurrence of paediatric Crohn’s disease by risk-based treatment and early monitoring
|
Kim, Esther S.
|
|
|
|
9 |
p. 377-381
|
artikel
|
| 94 |
Prompt intervention lowers seizure risk after traumatic brain injury
|
|
|
2001
|
|
9 |
p. 12-15
|
artikel
|
| 95 |
Quality use of medicines in neonatal care: a review of measures of quality used to evaluate the appropriateness and rational use of medication within the NICU
|
Krzyzaniak, Natalia
|
|
2016
|
|
9 |
p. 392-402
|
artikel
|
| 96 |
Quinupristin/dalfopristin and linezolid have important roles in the treatment of infections due to vancomycin-resistant enterococci
|
|
|
2002
|
|
9 |
p. 14-17
|
artikel
|
| 97 |
Ranibizumab: points to consider when using it to treat neovascular age-related macular degeneration according to EU labelling
|
Lyseng-Williamson, Katherine A.
|
|
2013
|
|
9 |
p. 268-274
|
artikel
|
| 98 |
Ravulizumab in paroxysmal nocturnal hemoglobinuria: a profile of its use
|
McKeage, Kate
|
|
2019
|
|
9 |
p. 405-412
|
artikel
|
| 99 |
Reduce the risk of QT interval prolongation associated with targeted cancer therapy by using arrhythmic risk stratification and prevention strategies
|
|
|
2017
|
|
9 |
p. 430-434
|
artikel
|
| 100 |
Relieving the pain of postherpetic neuralgia with lidocaine patch 5%
|
|
|
2000
|
|
9 |
p. 1-3
|
artikel
|
| 101 |
Rheumatic fever: a preventable and treatable public health problem
|
|
|
2000
|
|
9 |
p. 5-8
|
artikel
|
| 102 |
Rheumatic fever: a preventable and treatable public health problem
|
|
|
|
|
9 |
p. 5-8
|
artikel
|
| 103 |
RTS,S/AS01 malaria vaccine (Mosquirix®): a profile of its use
|
Syed, Yahiya Y.
|
|
|
|
9 |
p. 373-381
|
artikel
|
| 104 |
Some phytomedicines show promise for the management of migraine, but further clinical evidence is needed before they can be strongly recommended
|
|
|
2019
|
|
9 |
p. 413-417
|
artikel
|
| 105 |
Sufentanil sublingual tablet system in the treatment of acute postoperative pain in adults: a profile of its use
|
Lyseng-Williamson, Katherine A.
|
|
2017
|
|
9 |
p. 409-417
|
artikel
|
| 106 |
Suspicious drug hypersensitivity reactions in pediatric patients: a retrospective single-center study
|
Ozdemir, Pinar Gokmirza
|
|
2017
|
|
9 |
p. 435-441
|
artikel
|
| 107 |
Take an individualized approach when managing pain in the elderly at the end of life
|
|
|
2012
|
|
9 |
p. 10-12
|
artikel
|
| 108 |
Take an individualized, holistic approach when managing epileptic encephalopathies
|
|
|
2013
|
|
9 |
p. 275-279
|
artikel
|
| 109 |
Tapinarof cream 1% in plaque psoriasis: a profile of its use
|
Shirley, Matt
|
|
|
|
9 |
p. 303-308
|
artikel
|
| 110 |
Tattooing is possible in many patients with medical or skin conditions as long as disease-specific recommendations are followed
|
|
|
2018
|
|
9 |
p. 425-428
|
artikel
|
| 111 |
The empirical choice of antibacterial agents in intra-abdominal infections requires consideration of a variety of factors
|
|
|
2012
|
|
9 |
p. 13-16
|
artikel
|
| 112 |
The role of the hospital pharmacist in immunocellular therapy with chimeric antigen receptor (CAR) T cells
|
Braga, Florbela
|
|
|
|
9 |
p. 433-438
|
artikel
|
| 113 |
Tisotumab vedotin-tftv in previously treated recurrent or metastatic cervical cancer: a profile of its use in the USA
|
Kim, Esther S.
|
|
|
|
9 |
p. 382-388
|
artikel
|
| 114 |
Treat elderly patients hospitalized for community-acquired pneumonia early based on infection severity and risk factors
|
|
|
2017
|
|
9 |
p. 424-428
|
artikel
|
| 115 |
Treat infected venous leg ulcers with appropriate culture-based antimicrobials and usual wound care
|
|
|
2016
|
|
9 |
p. 381-384
|
artikel
|
| 116 |
Treatment of nocturia in the elderly depends on underlying cause
|
|
|
2000
|
|
9 |
p. 8-12
|
artikel
|
| 117 |
Treat psoriasis with traditional and novel topical therapies
|
Fenton, Caroline
|
|
|
|
9 |
p. 400-405
|
artikel
|
| 118 |
Ulipristal acetate: a guide to its use in uterine fibroids
|
Lyseng-Williamson, Katherine A.
|
|
2012
|
|
9 |
p. 1-4
|
artikel
|
| 119 |
Various interventions have potentially major economic impact in intermittent claudication
|
|
|
2002
|
|
9 |
p. 23-25
|
artikel
|
| 120 |
Vital to monitor, prevent and treat metabolic and cardiovascular adverse events induced by long-term systemic glucocorticoid therapy
|
|
|
2015
|
|
9 |
p. 313-315
|
artikel
|
| 121 |
When treating chronic pelvic pain in women, consider peripheral and central contributors
|
|
|
2017
|
|
9 |
p. 418-423
|
artikel
|
Tijdschrift beschrijving